Evidence map›Paper›PMID 34987684›Full record

ArticleRadiology case reports2022

A case with primary hyperaldosteronism associated with chronic kidney disease.

Vilma Cadri, Elvana Rista, Florian Toti, Bahadir Celep, Sokol Shehu, Blertina Dyrmishi, Fjolla Hyseni, Eram Ahsan, Diana Hla, Ali Guy and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Radiology case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Vilma CadriUniversity Hospital Center "Mother Teresa", Tirana, Albania.
Elvana RistaHygeia Hospital, Tirana, Albania.
Florian TotiUniversity Hospital Center "Mother Teresa", Tirana, Albania.
Bahadir CelepHygeia Hospital, Tirana, Albania.
Sokol ShehuHygeia Hospital, Tirana, Albania.
Blertina DyrmishiHygeia Hospital, Tirana, Albania.
Fjolla HyseniResearch Fellow, Department of Urology, Langone Health, NYC, New York, USA.
Eram AhsanDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Diana HlaMayo Clinic Alix School of Medicine, Rochester, MN, USA.
Ali GuyClinical Instructor of Physical Medicine & Rehabilitation, New York University School of Medicine, NYU Medical Center, NYC, NY, USA.
Samar IkramDepartment of Neurological Surgery, Mayo Clinic, Rochester, MN, USA.
Abdur RahmanDepartment of Medicine, Life and Care Hospital Ltd, Dhaka, Bangladesh.
Muhammad TahirLife Care International Hospital, Islamabad, Pakistan.
Juna MusaDepartment of Surgery, Biomedical Engineering, and Physiology, Mayo Clinic, Rochester, MN, USA.
Academy of Sciences of Albania · ALMayo Clinic · USMother Teresa Hospital · ALNYU Langone Health · USMayo Clinic in Arizona · USShifa International Hospital · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary hyperaldosteronism (PA) is one of the most common causes of secondary hypertension. PA may be associated with a decline in renal function. About 20% of cases with resistant HTN eventually cause PA, so all these patients should be evaluated for PA. Herein, we present a case with drug-resistant hypertension and chronic kidney disease (CKD), the cause of which was PA. Despite his low-salt diet modifications and treatment with several classes of antihypertensive medication, he had poorly controlled blood pressure (BP). Measurements of aldosterone and renin raised the concern of PA. Imaging confirmed bilateral adrenal hyperplasia. Due to the persistently high BP, despite the modification of the antihypertensive treatment, the patient underwent unilateral adrenalectomy, as the only feasible possibility of lowering aldosterone levels. After surgery, the patient had an improvement in both BP values and renal function. PA is difficult to diagnose in patients with CKD and Arterial Hypertension because hypertension is often associated with CKD, but PA accounts for a significant percentage of drug-resistant hypertension, so these patients should be screened for secondary arterial hypertension.

Indexed as

Chronic kidney disease (CKD)Primary hyperaldosteronism (PA)Resistant hypertension

Identifiers

PMID34987684
PMCPMC8693419
OpenAlexW4205596630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.